Clinical trials in El Salvador
80 studies list at least one site in El Salvador. 14 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-10-29.
Get an email when these change. Save the studies in El Salvador recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Most studied here
Who runs them
Hoffmann-La Roche (8) · The Cleveland Clinic (6) · Boehringer Ingelheim (5) · DermBiont, Inc. (4) · Carl Zeiss Meditec AG (2) · Aurion Biotech (2) · AstraZeneca (2) · Bayer (2)
What changed recently
From the registry's own updates since Oct 13, 2026.
Stopped1
- Feasibility Study of an Accommodating IOL DesignTerminatedOct 29, 2026NCT07147192
Newly registered3
- A Study to Evaluate the Efficacy and Safety of TP-06 for PCEDOct 21, 2026NCT07886268
- Safety and Efficacy of Cultivated Allogeneic Corneal Endothelial Cells Attached to a Hydrogel Substrate (Endo-Tek™) as a Treatment for Corneal Endothelial Cell DysfunctionOct 15, 2026NCT07874503
- Radiosurgery for Severe Refractory Cancer Pain: A Sham-Controlled Pilot TrialOct 13, 2026NCT07871123
Studies
Recruiting first, then most recently updated. Showing 50 of 80 — search for more.
- A Study to Evaluate the Efficacy and Safety of TP-06 for PCEDRecruitingNCT07886268Phase 2
- Safety and Efficacy of Cultivated Allogeneic Corneal Endothelial Cells Attached to a Hydrogel Substrate (Endo-Tek™) as a Treatment for Corneal Endothelial Cell DysfunctionRecruitingNCT07874503Phase 1
- CAYA Cancer Retrospective Cohort StudyRecruitingNCT07246213
- CAYA Cancer Prospective Cohort StudyRecruitingNCT07632014
- Point of Care - Triage and Treatment for Cervical Pre-cancerRecruitingNCT07461818Not applicable
- Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (Phase 2)RecruitingNCT07538050Not applicable
- The Vizio Clinical StudyRecruitingNCT06591117Not applicable
- An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's HealthNot yet recruitingNCT05477953
- Organ Dysfunction Score for Obstetric PatientsRecruitingNCT07068022
- Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical CancerRecruitingNCT06815939Not applicable
- An Early Feasibility, Prospective, Single-Arm Study of the Polaris SystemRecruitingNCT06990074Not applicable
- Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-samplingRecruitingNCT07232355
- Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - PediatricsRecruitingNCT05566431Not applicable
- Randomized Study Using SM-030 Gel for Adults With MelasmaRecruitingNCT06454747Phase 2
- Feasibility Study of an Accommodating IOL DesignTerminatedNCT07147192Not applicable
- AI Telemedicine Support for Primary Care Physicians in El SalvadorCompletedNCT07406919Not applicable
- Radiosurgery for Severe Refractory Cancer Pain: A Sham-Controlled Pilot TrialTerminatedNCT07871123Not applicable
- Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal AtrophyCompletedNCT05617820Phase 3
- Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation DeviceCompletedNCT03429582Not applicable
- Introducing a Telemedicine Strategy to Deliver Cervical Cancer Screening Results in El SalvadorCompletedNCT07482306Not applicable
- Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal SurgeryCompletedNCT07508592Not applicable
- Efficacy and Safety Study of Moxidectin in Adults With ScabiesCompletedNCT05875441Phase 2
- Single Visit Clinical Validation of ScreenFire, a Low-cost HPV TestActive, not recruitingNCT05431699Not applicable
- To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque PsoriasisCompletedNCT04566666Phase 2
- To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic DermatitisCompletedNCT04684485Phase 2
- A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerCompletedNCT01358877Phase 3
- A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea VersicolorCompletedNCT04937920Phase 2
- American Registry of Ambulatory or Acutely Decompensated Heart FailureCompletedNCT05295641
- An Innovative Treatment for Cervical Precancer (UH3)CompletedNCT03084081Not applicable
- Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)CompletedNCT02798471Phase 3
- Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial DysfunctionActive, not recruitingNCT06630169Phase 2
- Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01734785Phase 3
- A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial DysfunctionCompletedNCT05309135Phase 1
- National Evaluation of Quality of Childcare (C0682)CompletedNCT02534597Not applicable
- Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive CandidiasisCompletedNCT02244606Phase 2
- Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract SurgeryCompletedNCT06192901
- Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and LentigosCompletedNCT05511948Phase 2
- Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic KeratosisActive, not recruitingNCT05136144Phase 2
- Comparison of Two Preoperative Antiseptic Solutions Alcohol Based in Abdominal Elective SurgeriesTerminatedNCT03859908Phase 4
- Exploratory Clinical Study for Techniques Associated With the Fluid Accommodating IOLCompletedNCT04330001Not applicable
- Study to Optimize the IOL Constant of a New Multifocal Intraocular LensTerminatedNCT05201027Not applicable
- Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast CancerCompletedNCT02594371Phase 3
- Antibiotic Resistance in Global Pediatric Oncology CentersCompletedNCT03721562
- Clinical Evaluation of the Next Generation Phaco SystemCompletedNCT04332640Not applicable
- A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast CancerCompletedNCT01966471Phase 3
- Heart Failure IDentification in a High Risk Cardiovascular OutpatiEnt Population (HIDE)CompletedNCT04143919Not applicable
- Effects of the WHO 8-step Wheelchair Service Delivery Process on Wheelchair Users in El Salvador: a Cohort StudyCompletedNCT04936087Not applicable
- High Risk Crack Use Settings and HIV in El SalvadorCompletedNCT01279421Not applicable
- A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerCompletedNCT01566721Phase 3
- Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial SeizuresCompletedNCT00537940Phase 4